Filing Details

Accession Number:
0001818382-24-000186
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-11 17:53:12
Reporting Period:
2024-09-10
Accepted Time:
2024-09-11 17:53:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1818382 Humacyte Inc. HUMA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654316 Kathleen Sebelius 2525 East North Carolina Highway 54
Durham NC 27713
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-10 4,521 $4.34 43,910 No 4 M Direct
Common Stock Disposition 2024-09-10 3,634 $5.41 40,276 No 4 S Direct
Common Stock Acquisiton 2024-09-10 2,479 $3.35 42,755 No 4 M Direct
Common Stock Disposition 2024-09-10 1,548 $5.39 41,207 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2024-09-10 4,521 $0.00 4,521 $4.34
Common Stock Stock Options (right to buy) Disposition 2024-09-10 2,479 $0.00 2,479 $3.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,979 2024-08-09 2032-06-09 No 4 M Direct
6,021 2024-08-15 2033-06-15 No 4 M Direct
Footnotes
  1. The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $5.411 to $5.42. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $5.38 to $5.40. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.